Target intelligence / Profile preview

NOD-like receptor protein 3 (NLRP3)

Target
NLRP3
Molecular classification
Pattern recognition receptor (PRR), NOD-like receptor (NLR) family, Inflammasome component
01

Overview

NOD-like receptor protein 3 (NLRP3) is a cytosolic pattern recognition receptor predominantly expressed in macrophages. It serves as a sensor for pathogen-associated molecular patterns and danger signals from damaged cells. Upon activation by diverse stimuli—including extracellular ATP, crystalline uric acid, or microbial components—NLRP3 oligomerizes with the adaptor ASC and pro-caspase‑1 to form the NLRP3 inflammasome complex. This leads to autocatalytic activation of caspase‑1, which processes pro-inflammatory cytokines interleukin‑1β and interleukin‑18 into their active forms for secretion. Caspase‑1 also cleaves gasdermin D, triggering pyroptotic cell death. The NLRP3 inflammasome plays a central role in host defense but is also implicated in numerous inflammatory diseases when dysregulated. Pharmacological inhibitors such as MCC950 and dapansutrile are under investigation for treating conditions driven by aberrant NLRP3 activity.

Other names
NACHT, LRR and PYD domains-containing protein 3CryopyrinCIAS1PYPAF1
02

Mechanism of action

Direct inhibition of NLRP3 oligomerization/activation by small molecules such as MCC950 and dapansutrile, preventing assembly of the inflammasome complex and subsequent activation of caspase‑1 and release of pro-inflammatory cytokines

03

Biological functions

Innate immune responseInflammation signalingCytokine maturation (IL-1β, IL-18)Induction of pyroptosis (inflammatory cell death)
04

Disease associations

InflammationMetabolic disorders (e.g., atherosclerosis, type 2 diabetes)Autoimmune diseases (e.g., rheumatoid arthritis)Neurodegenerative diseases (e.g., Alzheimer’s disease)Cardiovascular diseaseInfection-related hyperinflammation
05

Safety considerations

Risk of immunosuppression or increased susceptibility to infection due to broad inhibition of innate immune responsesPotential off-target effects with small molecule inhibitors targeting conserved domains in related proteins
06

Interacting drugs

MCC950

1 more in the full profile.

07

Biomarkers

IL‑1β levelsIL‑18 levelsCaspase‑1 activityGasdermin D cleavage products

Beyond the preview

Go deeper on NOD-like receptor protein 3 (NLRP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NOD-like receptor protein 3 (NLRP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call